The differences between PCI and Fibrinolytic therapy in Acute ST  elevation Myocardial Infarction

Kurbanova Dilnozakhon, Sa’idaliyev Rustam Sa’idaliyevich, Jabborov Ozimboy Otaxanovich, Tursunova Laylo Dilshadovna

dc.contributor.author	Kurbanova Dilnozakhon, Sa’idaliyev Rustam Sa’idaliyevich, Jabborov Ozimboy Otaxanovich, Tursunova Laylo Dilshadovna
dc.date.accessioned	2022-09-30T05:24:31Z
dc.date.available	2022-09-30T05:24:31Z
dc.date.issued	2022
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/2353
dc.description.abstract	In recent decades, coronary heart disease (CHD) remains the main cause of mortality among the employable population (Oganov R.G. Maslennikova G.Y., 2013). According to epidemiological data, cardiovascular diseases account for 20-42% of deaths. Of these, 51% account for coronary heart disease. Recent studies have significantly expanded the understanding of the pathogenesis of these diseases.	en_US
dc.language.iso	en	en_US
dc.publisher	Ўзбекистон	en_US
dc.subject	Percutaneous coronary intervention(PCI), Fibrinolysis, ST elevation myocardial infarction, Reperfusion therapy.	en_US
dc.title	The differences between PCI and Fibrinolytic therapy in Acute ST elevation Myocardial Infarction	en_US
dc.type	Article	en_US